Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study-论文-万方医学网

Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study

导出原文传递

翻译打印收藏纠错

作者： Goto, Yasushi ^[1] ; Yamamoto, Nobuyuki ^[2] ; Masters, Elizabeth T. ^[3] ; Kikkawa, Hironori ^[4] ; Mardekian, Jack ^[5] ; Wiltshire, Robin ^[6] ; Togo, Kanae ^[7] ; Ohe, Yuichiro

作者单位： Pfizer Ltd, Oncol Global Med Affairs, Tadworth KT20 7NS, Surrey, England ^[1] Pfizer Japan Inc, Corp Affairs Hlth & Value, Shibuya Ku, Shinjuku Bunka Quint Bldg 3-22-7, Tokyo ^[2] Natl Canc Ctr Hosp, Dept Thorac Oncol, 5 Chome 1-1 Tsukiji, Chuo City, Tokyo 1040045, Japan ^[3] Wakayama Med Univ, Dept Internal Med, 811-1 Kimiidera, Wakayama, Wakayama 6418509, Japan ^[4] Pfizer Inc, Hlth Econ & Outcomes Res, 235 E 42 St, New York, NY USA ^[5] Pfizer Japan Inc, Med Affairs, Oncol, Shibuya Ku, Shinjuku Bunka Quint Bldg 3-22-7, Tokyo 1510053 ^[6] Pfizer Inc, Stat, 235 E 42 St, New York, NY USA ^[7]

关键词 Advanced non-small cell lung cancer Alectinib Anaplastic lymphoma kinase Crizotinib Medical data vision Tyrosine kinase inhibitor

发布时间 2022-10-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除